Iceland Press Releases

Published on April 6, 2023 - 06:14 GMT

L.A.B gear up to tour Australia, USA, Europe & The UK

L.A.B ANNOUNCE THEIR TOUR DATES FOR 2023 AS THEIR SINGLE, ‘TAKE IT AWAY’ BECOMES THEIR LATEST HIT LONDON, UNITED KINGDOM, April 6, 2023 /⁨EINPresswire.com⁩/ -- ‘Take It Away’ brings together all elements of the L.A.B sound - reggae-inspired groove, …

Distribution channels: Agriculture, Farming & Forestry Industry, Amusement, Gaming & Casino ...

Published on April 3, 2023 - 13:28 GMT

EndoSure appoints Ferdinand Medical as the exclusive Nordic distributor for non-invasive endometriosis test

Revolutionary EndoSure Test set to transform endometriosis diagnosis & treatment across Norway, Sweden, Denmark, and Iceland. SPARKS GLENCOE, MARYLAND, UNITED STATES, April 3, 2023 /⁨EINPresswire.com⁩/ -- ENDOSURE, Inc. appoints Ferdinand Medical ApS …

Distribution channels: Beauty & Hair Care, Business & Economy ...

Published on March 28, 2023 - 17:04 GMT

Groundbreaking AI-Powered 'Press Release Generator' Launched by EIN Presswire

First-to-market innovative AI technology enables users to write press releases. WASHINGTON , D.C., USA, March 28, 2023 /⁨EINPresswire.com⁩/ -- EIN Presswire, a division of Newsmatics Inc., announced the launch of its groundbreaking AI-powered "Press …

Distribution channels: Agriculture, Farming & Forestry Industry, Amusement, Gaming & Casino ...

Published on March 28, 2023 - 09:00 GMT

Alvotech Provides Update on Corporate Sustainability Framework

REYKJAVIK, Iceland, March 28, 2023 (GLOBE NEWSWIRE) -- Alvotech (Nasdaq: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced an update to the …

Distribution channels: Technology

Published on March 17, 2023 - 13:10 GMT

Alvotech to Present Clinical Study Data for AVT04, a Proposed Biosimilar to Stelara®, at 2023 American Academy of Dermatology (AAD)...

Alvotech to present two posters related to pharmacokinetics and confirmatory clinical studies for AVT04 (ustekinumab), a proposed biosimilar to Stelara® Marketing applications for AVT04 have been submitted in major markets including U.S. and Europe …

Distribution channels: Technology

Published on March 1, 2023 - 15:05 GMT

GOP Rep. Gaetz Cited Chinese Propaganda, Failed to Use Perspectify News Index to Distinguish Propaganda from Real News

News tech company Newsmatics recently launched a news propaganda identification service that can help readers avoid falling into the trap of fake news. WASHINGTON , D.C., USA, March 1, 2023 /⁨EINPresswire.com⁩/ -- At a recent congressional hearing, …

Distribution channels: Agriculture, Farming & Forestry Industry, Amusement, Gaming & Casino ...

Published on March 1, 2023 - 21:30 GMT

Alvotech Reports Financial Results for Full Year 2022 and Provides Business Update

Full year 2022 total revenue, including other income, increased by 114% to $85.0 million, compared to $39.7 million in 2021, driven by both milestone revenue and product revenue from commercialization of AVT02, a biosimilar to Humira®, in 17 countries …

Distribution channels: Business & Economy, Technology ...

Published on February 28, 2023 - 07:42 GMT

AMF, the French Financial Markets Authority, Approves BlockchainValley 4IR Utility Token (ICO) Public Sale

4IR Tokens can be used as a means of payment to acquire goods for products and services that will be offered on the E-commerce Platform, and incentive rewards PARIS, FRANCE, February 28, 2023 /⁨EINPresswire.com⁩/ -- Blockchain Valley SAS (“ …

Distribution channels: Agriculture, Farming & Forestry Industry, Amusement, Gaming & Casino ...

Published on February 28, 2023 - 00:15 GMT

Alvotech Announces Webcast of 2022 Full Year Financial Results at 8:00 am ET on March 2, 2023

REYKJAVIK, Iceland, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 23, 2023 - 14:00 GMT

Icelandic Manufacturer Drives Environmentalism With New Wool Technology

REYKJAVÍK, Iceland, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Icewear, the leading manufacturer and retailer of Icelandic wool products, has been operating in a changing market environment. One could say that responding to the travel restrictions and influxes in …

Distribution channels:

Published on February 10, 2023 - 21:01 GMT

Settlement of Alvotech Private Share Placement Completed

REYKJAVIK, Iceland, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today the completion of the equity transaction …

Distribution channels: Technology

Published on February 9, 2023 - 07:48 GMT

EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) BAD VILBEL, HESSEN, GERMANY, February 9, 2023 /⁨EINPresswire.com⁩/ -- EMA Confirms Acceptance of …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 9, 2023 - 07:30 GMT

EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) EMA opinion on AVT04 could come as soon as the second half of 2023 Reference product Stelara® (ustekinumab …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 6, 2023 - 09:00 GMT

Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Proposed Biosimilar to Xolair® (Omalizumab)

Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia, and New Zealand REYKJAVIK, Iceland, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global …

Distribution channels: Companies, Technology ...

Published on January 24, 2023 - 09:00 GMT

Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia

AVT02 as Simlandi™ is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure REYKJAVIK, Iceland and DUBAI, United Arab Emirates, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Bioventure, a wholly …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 23, 2023 - 08:24 GMT

Alvotech Completes $137 Million Private Share Placement

REYKJAVIK, Iceland, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement of …

Distribution channels: Technology

Published on January 16, 2023 - 14:19 GMT

Craft Beer Marketing Awards Announces New Tattoo Category for Charity

Proceeds of global competition's new category to benefit The Michael James Jackson Foundation to fund scholarships for people of color entering brewing industry MELVILLE, NEW YORK, USA, January 16, 2023 /⁨EINPresswire.com⁩/ -- In the spirit of giving …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...

Published on January 13, 2023 - 09:00 GMT

Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate

REYKJAVIK, Iceland and TOKYO, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Japanese pharmaceutical company Fuji …

Distribution channels: Companies, Technology ...

Published on January 11, 2023 - 09:00 GMT

Alvotech Initiates Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®

REYKJAVIK, Iceland, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today the initiation of a pharmacokinetic …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 10, 2023 - 13:15 GMT

New Emergency Department Study Shows NeurOptics’ Neurological Pupil Index™ is Unaffected by Clinical Intoxication

Results show Automated Pupillometer and NPi® can be used for patient evaluation and triage without risk of confounding by key intoxicants of abuse IRVINE, CALIF., USA, January 10, 2023 /⁨EINPresswire.com⁩/ -- A newly published clinical study shows that …

Distribution channels: Culture, Society & Lifestyle, Electronics Industry ...

Iceland Press Releases Distributed by EIN Presswire